** Hong Kong shares of Consun Pharmaceutical Group Ltd 1681.HK
fall as much as 12.4% to HK$3.95, their lowest since February
2017, and are on track for 4th straight session of losses
** Stock ranks the 2nd biggest percentage decliner in the
afternoon trade, and is heading for the worse day on record with
steepest percentage decline since listing in December 2013
** Kidney medicines maker expects to see its 2019 profit to
drop 70-80% from a year ago due to decrease in sales revenue of
its Yulin pharmaceutical segment amid intensified competition in
the over-the-counter drug market in China urn:newsml:reuters.com:*:nFWN29D0VI
** Guangdong-based pharmaceutical products maker has
underperformed the Hang Seng Commerce & Industry Index sector
.HSNC by 8.5 percentage points in the past one month
** The Hong Kong Hang Seng Commerce & Industry Index .HSNC
rises 1.4% on Thursday
** The Hang Seng China enterprises index .HSCE climbs
1.4%, and the benchmark index .HSI gains 1.3%
((Reuters Messaging:
donny.kwok.thomsonreuters.com@reuters.net))